Brief: ImmuCell Corporation Q2 product sales USD 3.533 million
10/08/2023 21:48
Aug 10 (Reuters) - ImmuCell Corporation Q2 EPS USD -0.18. * Q2 pretax profit USD -1.378 million * Q2 net income USD -1.38 million * Q2 basic EPS USD -0.18 * Q2 product sales USD 3.533 million * Q2 operating expenses USD 2.348 million
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year